Targeting KEAP1/Nrf2, AKT, and PPAR-γ signals as a potential protective mechanism of diosmin against

Fares E M Ali1, Ahmed M Sayed2, Ali H El-Bahrawy1

  • 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt.

Life Sciences
|March 21, 2021
PubMed
Abstract

Insights

Diosmin (DS) protects against gentamicin (GM)-induced kidney damage by restoring antioxidant balance and targeting key signaling pathways. This study highlights DS as a potential therapeutic agent for preventing nephrotoxicity.

Area of Science:

  • Pharmacology and Toxicology
  • Biochemistry
  • Nephrology

Background:

  • Gentamicin (GM) is a vital antibiotic for severe infections but causes nephrotoxicity, limiting its use.
  • Diosmin (DS), a flavonoid, has diverse bioactivities, but its protective effects against GM-induced kidney damage are not well understood.

Purpose of the Study:

  • To investigate the potential protective effects of Diosmin (DS) against Gentamicin (GM)-induced nephrotoxicity in a rat model.
  • To elucidate the underlying molecular mechanisms involving key signaling pathways.

Main Methods:

  • Rats were treated with GM (100 mg/kg) for 7 days, with or without co-administration of DS (50 mg/kg).
  • Kidney function, oxidant/antioxidant status, and expressions of Nrf2, GCLC, HO-1, SOD-3, AKT, KEAP1, and PPAR-γ were assessed.
  • In-silico analysis was performed to confirm binding affinities of DS to target proteins.

Main Results:

  • GM induced kidney dysfunction, oxidative stress, and altered expressions of Nrf2, AKT, and PPAR-γ signaling molecules.
  • DS treatment significantly attenuated GM-induced nephrotoxicity, restored oxidant/antioxidant balance, and modulated the expression of key proteins.
  • In-silico studies supported the biochemical findings, showing binding affinity of DS to KEAP1, AKT, and PPAR-γ.

Conclusions:

  • Diosmin (DS) demonstrates significant protective effects against Gentamicin (GM)-induced nephrotoxicity.
  • DS acts by targeting the KEAP1/Nrf2/ARE, AKT, and PPAR-γ signaling pathways.
  • DS is a promising therapeutic candidate for preventing GM-induced kidney damage.